Year: 2023
Type: conference-abstract
Abstract: The Plaque Reduction Neutralization Test (PRNT) is considered the gold standard to study Neutralizing Antibodies (NAbs), but due to its limitations, more scalable approaches are required. Focus Reduction Neutralization Test (FRNT) is suitable for automation which allows large-scale testing and data integrity. SARS-CoV-2 PRNT and FRNT must be held in Biosafety Level 3 (BSL-3) labs. To circumvent this issue, the use of SARS-CoV-2 Pseudovirus (PV) has enabled the manipulation in BSL-2 areas, increasing throughput and reducing costs.
Institution: Instituto de Tecnologia em Imunobiológicos
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4367155668
